Effects of atorvastatin and apoA-I/phosphatidylcholine discs on triglyceride-rich lipoprotein subfractions as characterized by capillary isotachophoresis

Clinica Chimica Acta; International Journal of Clinical Chemistry
Bo ZhangKeijiro Saku

Abstract

The present study examined the effects of atorvastatin and the in vitro effect of apolipoprotein (apo) A-I/phosphatidylcholine (POPC) discs on charge-based triglyceride-rich lipoprotein (TRL) subfractions in a patient with type III hyperlipoproteinemia (HLP) and the apoE2/2 phenotype. Charge-based lipoprotein subfractions were characterized by capillary isotachophoresis (cITP). cITP analysis was performed using plasma that had been prestained with a lipophilic dye on a Beckman P/ACE MDQ system. Treatment with atorvastatin for 4 weeks markedly decreased the slow (s)-migrating TRL subfraction and both fast- and slow-migrating low-density lipoprotein (LDL) subfractions, but did not affect the fast (f)-migrating TRL subfraction in this patient. ApoA-I/POPC discs consisted of two major charge-based subfractions that had the mobility of cITP fTRL and sTRL. Incubation of plasma from this patient in the presence of apoA-I/POPC discs caused not only a reduction in cITP fast- and intermediate-migrating HDL and an increase in cITP sHDL but also a reduction in fTRL and sTRL and an increase in sLDL. Atorvastatin and apoA-I/POPC discs decreased cITP TRL subfractions in a complementary manner, suggesting that the combination of apoA-I/POPC di...Continue Reading

References

Aug 1, 1977·Atherosclerosis·J L De GennesJ Truffert
Jan 1, 1978·The Journal of Clinical Investigation·R J HeinenD S Fredrickson
Jul 1, 1996·Atherosclerosis·J Davignon, J S Cohn
Feb 12, 1998·Electrophoresis·G SchmitzV Richter
Dec 31, 1997·Arteriosclerosis, Thrombosis, and Vascular Biology·J R BurnettM W Huff
Apr 9, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·M N NanjeeN E Miller
Oct 16, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·J S CohnJ Davignon
May 16, 2000·Clinica Chimica Acta; International Journal of Clinical Chemistry·M OkazakiK Nakajima
May 8, 2002·The Journal of Clinical Endocrinology and Metabolism·Dick C ChanTrevor G Redgrave
Sep 18, 2002·Journal of Lipid Research·Jeffrey S CohnJean Davignon
Feb 8, 2003·Atherosclerosis. Supplements·Roger S Newton, Brian R Krause
Apr 10, 2003·The Journal of Pharmacology and Experimental Therapeutics·Khadija OuguerramMichel Krempf

❮ Previous
Next ❯

Citations

Jan 13, 2016·Chemistry and Physics of Lipids·Agnieszka ĆwiklińskaMaciej Jankowski
Dec 23, 2008·Electrophoresis·Petr GebauerPetr Bocek

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.